These investigations demonstrate that expression of the inhibitor of apoptosis family member, survivin, is dramatically increased during immortalization of nontransformed human fibroblasts that were transduced with telomerase reverse transcriptase (hTERT). Expression of survivin in immortalized fibroblasts peaked during G 2 /M phase of the cell cycle. However, the upregulation of survivin was dissociated from the rate of proliferation and proportion of G 2 /M cells. Depletion of survivin from immortal fibroblasts increased sensitivity to stress-induced apoptosis and resulted in an accumulation of cells with 4N DNA content. Conversely, overexpression of survivin in mortal fibroblasts conferred resistance to apoptosis. In contrast, very low levels of survivin in proliferating parental fibroblasts had no bearing on sensitivity to apoptosis. The upregulation of survivin did not appear to be a direct consequence of hTERT transduction. However, repression of hTERT resulted in the rapid downregulation of survivin in telomerase-immortalized fibroblasts and tumor cell lines, but not in cells immortalized via an Alternative Lengthening of Telomeres mechanism. These results have important therapeutic implications, as telomerase and survivin are both broadly expressed in human cancers. Selection during the immortalization process for cells expressing high levels of survivin may account for the abundance of survivin in diverse tumor types.
Introduction
The activation of a telomere maintenance mechanism during carcinogenesis prevents telomere shortening and enables proliferation beyond senescence (reviewed in Stewart and Weinberg, 2006) . In 80-90% of cancers, telomeres are maintained through the activity of the enzyme telomerase, whereas approximately 10% of cancers maintain telomere length via a recombinationbased mechanism known as Alternative Lengthening of Telomeres (ALT). Telomerase is also expressed in germ cells and various stem and progenitor cells, but is downregulated during differentiation (Hiyama et al., 1995; Wright et al., 1996) .
The human telomerase holoenzyme is a ribonucleoprotein complex that includes a reverse transcriptase (hTERT) as a catalytic domain, an RNA component (hTR) that functions as a template for reverse transcription, and the RNA binding and modifying protein, dyskerin (Cohen et al., 2007) . Ectopic expression of hTERT is sufficient to reconstitute telomerase enzyme activity, elongate telomeres and extend the lifespan of BJ foreskin fibroblasts and retinal epithelial cells (Bodnar et al., 1998) . However, telomere length independent mechanisms that involve the p16 INK4a /RB and/or p53 tumor suppressor pathways and/or other uncharacterized molecular events restrict the immortalization of many cell types, including human lung fibroblasts, bone marrow endothelial cells, keratinocytes and mammary epithelial cells (Kiyono et al., 1998; MacKenzie et al., 2000 MacKenzie et al., , 2002 Milyavsky et al., 2003; Taylor et al., 2004; Wen et al., 2006) .
Another common molecular feature of diverse tumor types is the abundant expression of survivin. Similar to telomerase, survivin is generally not detectable within the normal tissue surrounding tumors, although it has been demonstrated in normal human fetal tissue, testes and progenitor cells (Adida et al., 1998; Fukuda and Pelus, 2001) . Survivin was assigned to the inhibitor of apoptosis protein (IAP) family because it has a N-terminal baculoviral IAP repeat (Ambrosini et al., 1997) . However, it lacks a caspase recruitment domain and the carboxyterminal RING finger domain found in some other mammalian IAPs (Verhagen et al., 2001 ). An evolutionarily conserved nuclear export signal located between the baculoviral IAP repeat domain and carboxy terminus appears to be a key determinant of the dual functions of survivin in cell division and apoptosis (Li et al., 1999; Colnaghi et al., 2006; Knauer et al., 2006) .
Within the nucleus, survivin functions as an essential component of the chromosomal passenger complex (Uren et al., 2000) . Hence, depletion of survivin in tumor cells was shown to delay mitosis and result in defective cell division and polyploidy (Li et al., 1999; Carvalho et al., 2003; Lens et al., 2003) . Expression of survivin in tumor cells has also been shown to protect against apoptotic stimuli (Ambrosini et al., 1997; Wang et al., 2005; Knauer et al., 2007) . The precise mechanisms underlying the cytoprotective functions of survivin remain to be fully elucidated, however, its cytoplasmic localization provides an opportunity for direct or indirect effects on components of the apoptotic machinery (Dohi et al., 2004; Arora et al., 2007) . The cytoprotective function of survivin may account for the inverse correlation between the abundance of survivin in tumor cells and patient response to chemotherapy and radiotherapy (reviewed in Pennati et al., 2007) . Elevated levels of survivin in tumor cells positively correlate with various indicators of aggressive disease and shorter disease-free or overall survival. These observations suggest that survivin is upregulated during carcinogenesis and contributes to disease progression. However, as expression of survivin is cell cycle and developmentally regulated, an alternative explanation is that high levels of survivin detected in neoplastic versus normal cells simply reflects the high rate of proliferation of undifferentiated neoplastic cells.
Aside from correlations, the functional significance of survivin in premalignant cells of human origin has not yet been unequivocally demonstrated. In this study, it is shown that survivin is upregulated during immortalization of normal diploid fibroblasts. Elevated expression of survivin in immortalized fibroblasts protected against stress-induced apoptosis and showed no simple correlation with rate of proliferation. These results support the notion that the upregulation of survivin in cancer cells is reflective of an oncogenic event.
Results

MRC5 cells acquire resistance to apoptosis during hTERT-mediated immortalization
We previously demonstrated that hTERT-transduced MRC5 (MRC5hTERT) fibroblasts underwent a twofold increase in replicative lifespan before entering a telomere length-independent growth crisis, characterized by a reduced rate of expansion and an increased rate of cell death (MacKenzie et al., 2000; Taylor et al., 2004) . A subset of cells eventually escaped crisis and became immortalized. The immortalized cells retained functional properties of normal cells; they retained mitogenic requirements, were anchorage dependent, arrested in response to DNA damage and antimitotic agents, and were nontumorigenic. The rates of proliferation (0.40 ± 0.16 population doublings (PD)/day) and cell death (4.5±0.5% cell death by propidium iodide (PI) staining) in cultures of immortal cells were unaltered compared to early passage (25-55 PD) parental MRC5 cells (0.44±0.13 PD/day and 4.4±1.3% cell death). To determine whether the cells that escaped crisis and were immortalized had acquired resistance to cell death, the apoptotic potential of pre-and postcrisis MRC5hTERT cells was compared with parental MRC5 cells. In preliminary investigations, we determined that 100 nM okadaic acid (OA) and 1 mg/ml actinomycin D (ActD) very effectively induced apoptosis in MRC5 cells, whereas other agents, such as tumor necrosis factor-a, H 2 O 2 , Paclitaxel and Vincristine induced growth arrest and/or nonapoptotic cell death (data not shown). Apoptotic cell death was measured in MRC5 and MRC5hTERT cells treated with OA or ActD for 24 h by staining with Annexin V and PI. The results showed that postcrisis MRC5hTERT cells were significantly more resistant to apoptosis than parental MRC5 cells or precrisis MRC5hTERT cells (Po0.001; Figure 1a ). In addition, precrisis MRC5hTERT cells were slightly more resistant to ActD than parental MRC5 cells (Po0.05).
To confirm that apoptotic signaling was impaired in the immortal MRC5hTERT cells, caspase activation was investigated. Immunoblotting for the effector caspase, caspase-7, showed that the level of the proenzyme (35 kDa) in parental MRC5 and precrisis MRC5hTERT cells was reduced by treatment with OA or ActD (Figure 1b) . The reduction in pro-caspase-7 in these cells was accompanied by the appearance of a band of the expected size for active caspase-7 (20 kDa). No active caspase-7 was detected in drug-treated postcrisis MRC5hTERT cells (320 PD). ELISA assay confirmed that the induction of caspase-3/7 enzyme activity was blunted in postcrisis MRC5hTERT cells (Student's t-test, Po0.01; Figure 1c ). The enzymatic activity of caspase-9, which acts in the intrinsic apoptotic pathway upstream of effector caspase-3 and caspase-7, was also significantly reduced in OA-and ActD-treated MRC5hTERT cells compared with treated MRC5 cells (Figure 1d ). The reduction in caspase-9 activity was more dramatic in postcrisis than precrisis MRC5hTERT cells. Together, these results demonstrate that hTERT-immortalized MRC5 cells were defective in their ability to activate caspases involved in the intrinsic apoptotic pathway and consequently were resistant to cell death. The results also demonstrate a more moderate apoptotic defect in precrisis MRC5hTERT cells.
Survivin is upregulated during immortalization of human fibroblasts
The expression of survivin was assayed at various time points during immortalization. Quantitative real-time RT-PCR (qRT-PCR) and immunoblot analyses demonstrated very low levels of survivin mRNA and protein in proliferating MRC5 cells at 45 PD (Figure 2a) . Survivin protein and mRNA expression were both moderately upregulated in the precrisis MRC5hTERT mass culture and were expressed at very high levels in postcrisis MRC5hTERT cells. Expression of survivin was also upregulated in seven out of nine immortalized clones that were derived by limiting dilution of the MRC5hTERT mass culture at early passage (Taylor et al., 2004; Figure 2a, bottom panel) . The level of expression of survivin in MRC5hTERT cells bore no relationship to the proliferative rate, as the MRC5hTERT mass culture at 217 PD proliferated at the same rate as parental MRC5 cells at 45 PD (0.4 PD/ day; Figure 2a , bottom panel). Similarly, the rate of proliferation of MRC5hTERT clones (0.3-0.6 PD/day) was comparable to parental MRC5 cells at 45 PD, and did not correlate with the level of survivin expressed. Notwithstanding the lack of correlation between the proliferation and expression of survivin in early passage MRC5 and immortal MRC5hTERT cells, it was noted that survivin was not expressed in senescent MRC5 cells.
To determine whether expression of survivin was cell cycle dependent, immortalized MRC5hTERT cells (316 PD) and parental MRC5 cells (45 PD) were arrested in G 1 , S and G 2 /M phases by treatment with mimosine, thymidine and nocodazole, respectively (Figure 2b ). In immortal MRC5hTERT cells, survivin mRNA and protein were found to be highest in cells arrested in G 2 /M and lowest in G 1 -arrested cells. In contrast, expression of survivin was low in parental MRC5 cells at all phases of the cell cycle. Thus, the contrasting levels of survivin in unsynchronized MRC5 versus MRC5hTERT cells was not a reflection of the percentage of cells in a particular phase of the cell cycle, nor a consequence of increased proliferation.
Immunofluorescence staining demonstrated that survivin was expressed at a very high level within both the cytoplasm and nucleus of immortal MRC5hTERT cells (316 PD; Figure 2c ). There was a generally lower level of staining in both the cytoplasm and nucleus of precrisis MRC5hTERT cells (67 PD) and infrequent staining of parental MRC5 cells (45 PD). Nuclear and cytoplasmic expression of survivin was confirmed by immunoblotting proteins fractionated from the nucleus and cytosol (data not shown). There was no significant difference in the frequency of survivin-positive cells in cultures of immortal cells compared with precrisis MRC5hTERT cultures. The proportion of cells expressing nuclear versus cytoplasmic survivin was also very similar in precrisis and immortal MRC5hTERT cultures. These results indicate that the progressive upregulation of survivin in MRC5hTERT cells was principally due to an increased level of expression, rather than a substantially changed proportion of cells expressing survivin.
Expression of survivin was also assessed in hTERTimmortalized WI-38 lung fibroblasts and JFCF6 jejunal fibroblasts, as well as in JFCF6 cells that were immortalized by transfection with SV40 early region (ER) and spontaneous activation of either telomerase or ALT ( Figure 3 ). Consistent with the trend observed in MRC5 cells, expression of survivin mRNA and protein was dramatically increased in immortalized WI38h-TERT and JFCF6 cell lines, irrespective of the mode of immortalization of the JFCF6 cells. Survivin was also found to be upregulated in hTERT-immortalized BJ foreskin fibroblasts (data not shown).
Elevated expression of survivin confers resistance to apoptosis in immortalized fibroblasts
To investigate whether resistance to apoptosis was a direct consequence of the upregulation of survivin in MRC5hTERT cells, siRNA-mediated knockdown of survivin was performed. Postcrisis MRC5hTERT cells were transfected with four previously described siRNAs (S1-S4) or a scrambled oligonucleotide (Sc) as a control ( Figure 4a ). The most effective siRNA (S1), which consistently resulted in >95% mRNA knockdown, was used to test the antiapoptotic effect of survivin. Consistent with results in Figure 1 , immortal MRC5hTERT cells (320 PD) transfected with Sc were resistant to treatment with OA or ActD. However, transfection of the immortal cells with S1 resulted in a 3.5-fold increase in spontaneous apoptosis (untreated cells; Po0.05, Student's t-test) and significantly increased their sensitivity to OA-and ActD-induced apoptosis (Po0.05 and Po0.01, respectively, Student's t-test; Figure 4a , right graph). In contrast to the immortal cells, transfection of precrisis MRC5hTERT and parental MRC5 cells with S1 had no significant effect on the level of spontaneous or drug-induced apoptosis. Similar results were obtained when survivin was functionally ablated in MRC5 and MRC5hTERT cells by transduction with a replication-defective adenoviral vector encoding a dominant negative mutant survivin (Adv-T34A; Supplementary Figure 1 ; Mesri et al., 2001) . Consistent with the siRNA knockdown experiment, functional inactivation of survivin by Adv-T34A transduction restored the apoptotic response of postcrisis MRC5hTERT cells, but did not alter the level of apoptosis in OA-and ActD-treated precrisis MRC5hTERT and MRC5 cultures. Together, these results demonstrate that the high level of survivin expressed in immortal MRC5hTERT cells conferred resistance to stress-induced apoptotic cell death, whereas the low level of survivin expressed in normal MRC5 cells and precrisis MRC5hTERT cells was not protective. Additional knockdown experiments confirmed that survivin also confers resistance to apoptosis in other immortalized fibroblast cell lines, including hTERT-immortalized WI38 and ALT-immortalized MRC5 cells (Supplementary Figure 2) .
The effect of survivin upregulation was also investigated by transducing precrisis MRC5hTERT cells that had bypassed senescence (82 PD) and parental MRC5 cells (45 PD) with a retroviral vector encoding survivin (MIGR1-Survivin) or a control vector encoding green fluorescent protein (GFP) alone (MIGR1; Gurbuxani et al., 2005) . Overexpression of survivin was verified by immunoblot analysis and was shown to confer both MRC5 and MRC5hTERT cells with resistance to OAand ActD-induced apoptosis (Figure 4b ). There was no difference in the rate of proliferation of MRC5 and MRC5hTERT cells transduced with survivin compared with mock or GFP-transduced cells over 30 days posttransduction (data not shown). These results confirm that an abundance of survivin confers resistance to apoptosis in nontransformed human fibroblasts.
Repression of hTERT results in the downregulation of survivin in telomerase-immortalized fibroblasts and tumor cells To determine whether the upregulation of survivin in immortalized MRC5hTERT cells was linked to hTERT expression and/or telomerase enzyme activity, expression of hTERT was suppressed with siRNA. After screening eight different hTERT siRNAs for their effect on hTERT mRNA expression and telomerase enzyme activity, expression of survivin mRNA and protein were assessed in five transfectants that expressed substantially less hTERT mRNA (Figures 5a and b) . A dramatic reduction in the amount of survivin protein and mRNA was detected in the MRC5hTERT cells that were transfected with the siRNAs that most effectively suppressed hTERT and telomerase activity (T7 and T8). To confirm the specificity of the siRNA, six additional telomerase-positive cell lines and two telomerase-negative (ALT) cell lines were transfected with T8 siRNA. The cell line panel included MRC5 cells immortalized by infection with SV40 ER and spontaneous activation of either telomerase (MRC5V1) or ALT (MRC5V2) (Huschtscha and Holliday, 1983) , as well as four telomerase-positive tumor cell lines. qRT-PCR and Q-TRAP analyses confirmed that there was a dramatic downregulation of hTERT and telomerase enzyme activity in the telomerase-positive cells transfected with T8 ( Figure 5c ). Survivin mRNA and protein expression were also suppressed in telomerase-immortalized fibroblasts and tumor cells transfected with T8 (Figure 5d ). In contrast, survivin was not downregulated in the T8-transfected ALT cell lines. This result demonstrates that the downregulation of survivin in telomerase-positive cells was a specific effect of suppression of hTERT and/or telomerase activity and not an off-target effect of the T8 siRNA.
To discern between the possibilities that survivin was downregulated in T8-transfected cells as a consequence of repression of hTERT or inhibition of telomerase, immortalized MRC5hTERT cells and the A549 lung tumor cell line were transfected with siRNAs that targeted the RNA component of telomerase, hTR (TR2 and TR3). Transfection with TR2 suppressed expression of hTR and telomerase enzyme activity, but did not significantly alter survivin expression (Figures  6a-c) . Thus, maintenance of high levels of survivin in telomerase-immortalized fibroblasts and tumor cell lines was dependent on continued expression of hTERT, but appeared to be independent of hTR and telomerase enzyme activity. Cell cycle analyses were performed to determine whether the downregulation of survivin in T8-transfected cells was due to depletion of cells in G 2 /M. In four independent experiments there was a 10-14% reduction in the percentage of S phase cells in T8 transfectants (Figure 6d; Supplementary Figure 3) . This was concomitant to a small increase in the proportion of cells in G 1 (9-11%) and G 2 /M (2-5%). There was no substantial increase in sensescence-associated b-galactosidase activity, which remained below approximately 2% following repression of hTERT (data not shown). Thus, the lower level of survivin expressed in T8-transfected cells was not explained by a reduced proportion of cells in G 2 /M or by senescence. However, the downregulation of survivin may have been an indirect consequence of apparently defective S phase progression associated with repression of hTERT. There was no apparent effect of hTR knockdown on cell cycle profile. Cells depleted of survivin accumulated with 4N DNA content and developed polyploidy, as previously described ( Figure 6d; Supplementary Figure 3) (Carvalho et al., 2003; Lens et al., 2003) .
Discussion
In these investigations, isogenic cells were employed to demonstrate that expression of survivin increases dramatically during hTERT-driven immortalization of nontransformed fibroblasts. Increased expression of survivin was demonstrated in three hTERT-immortalized fibroblast strains (MRC5, WI-38 and JFCF6), and was also found to be upregulated in hTERT-immortalized BJ foreskin fibroblasts (additional data not shown). The expression of survivin in hTERT-immortalized MRC5 fibroblasts was cell cycle dependent, peaking in G 2 /M phase, as previously shown in tumor cells (Li et al., 1998) . However, there was no relationship between the level of survivin and the doubling rate of early passage mortal MRC5 and immortal MRC5hTERT cells. We have previously shown by bromodeoxyuridine and PI staining that hTERT-immortalized MRC5 and early passage MRC5 cells have a very similar cell cycle profile (MacKenzie et al., 2000) . These observations, together with data in this report showing that survivin was expressed at a very low level in G 2 /M arrested parental MRC5 cells, indicate that the high level of survivin expressed in immortal MRC5hTERT cells was not simply a reflection of the proportion of mitotic cells.
Immunoblotting and qRT-PCR analyses demonstrated that survivin was moderately upregulated in precrisis MRC5hTERT cells and was expressed at a very high level in immortal MRC5hTERT cells. Immunofluorescence staining revealed that survivin was upregulated in most of the cells (approximately 80%) in both the pre-and postcrisis cultures, although the intensity of the staining was higher in the postcrisis cells. These results indicate that the progressive upregulation of survivin detected by immunoblotting reflected an increased level of survivin expressed at the cellular level, rather than an increased proportion of survivin-positive cells in the culture. However, the upregulation of survivin appears to be an indirect effect of hTERT expression, as there was no substantial induction of survivin immediately upon transduction of MRC5 cells with hTERT (data not shown). The progressive upregulation of survivin observed in MRC5hTERT cultures most likely reflects selection during immortalization for cells that express very high levels of survivin. A subpopulation of cells expressing higher levels of survivin may have arisen as a consequence of spontaneous molecular alterations occurring during propagation of the hTERT-transduced cells. Higher levels of survivin may have provided a selective advantage by protecting cells against stresses encountered during immortalization. This possibility is consistent with our survivin knockdown experiments that showed the propensity of immortal MRC5hTERT cells to resist stress-induced apoptosis was dependent on high levels of survivin, whereas there was no apparent survival advantage conferred by low to moderate levels of survivin expressed in mortal MRC5 and precrisis MRC5hTERT cells. Selection for cells expressing high levels of survivin during immortalization may account for the very broad and abundant expression of survivin among diverse cancer types, as most cancers arise from an immortalized cell (Reddel, 2000) . Our results showing that telomerase activity was abundantly expressed in SV40 ER-transformed fibroblasts that were immortalized via ALT indicate that telomerase activity was not necessary for the upregulation of survivin. The upregulation of survivin in SV40 ER-transformed cells was not unexpected, because SV40 large T antigen inactivates p53 and pRB, both of which negatively regulate the expression of survivin (Hoffman et al., 2002; Mirza et al., 2002; Jiang et al., 2004) . In concordance with these observations, a recent study demonstrated that survivin was upregulated in human melanocytes transfected with SV40 ER (Raj et al., 2008) . However, the upregulation of survivin in MRC5hTERT cells cannot be attributed to inactivity of p53 and pRB, which were shown to function in response to DNA damage in immortal MRC5hTERT cells (Taylor et al., 2004) . Immunoblot analysis of the panel of MRC5hTERT clones also showed no correlation between the abundance of survivin and inactivation p16 INK4a , which is one of the upstream regulators of pRB (data not shown). A number of other signaling pathways that are implicated in the upregulation of survivin in cancer cells warrant investigation for potential involvement in the upregulation of survivin during immortalization of hTERT-transduced fibroblasts (Zhang et al., 2006) . In particular, it will be important to determine whether a defect in transforming growth factor-b (TGFb) signaling, which was identified in immortal MRC5hTERT and WI38hTERT cells, contributes to the high level of survivin expressed in these cells (Milyavsky et al., 2007) . This possibility is supported by two recent studies that have shown TGFb suppresses expression of survivin (Wang et al., 2008; Yang et al., 2008) .
The abundant expression of survivin in the immortal cells was dependent on continued expression of hTERT in all telomerase-positive cell lines tested, including cell lines with defective p53. Notably, survivin was downregulated within 48 h of hTERT-siRNA transfection, which precludes the possible involvement of critical telomere shortening, particularly since immortal ablation of hTERT was also not due to a reduction in the proportion of cells in G 2 /M phase. However, hTERT knockdown did result in an apparent cell cycle defect, evidenced by a reduced proportion of cells in S phase, which may have contributed to the downregulation of survivin. Downregulation of telomerase enzyme activity due to siRNA-mediated repression of hTR had no effect on cell cycle progression or the expression of survivin. Thus, it appears that it was the downregulation of hTERT, rather than telomerase enzyme activity, that caused the cell cycle defect and suppression of survivin in T8-transfected cells. It is also possible that the downregulation of survivin was a direct or indirect effect of chromatin reorganization, as hTERT repression in human fibroblasts was previously shown to alter chromatin architecture (Masutomi et al., 2005) . However, the repression of survivin in hTERTsiRNA-transfected cells was not reflective of a generalized effect on gene expression, as qRT-PCR analyses showed that the expression of two other IAPs (cIAP-1 and cIAP-2) were unaltered in hTERT siRNA-transfected immortal MRC5hTERT cells (data not shown). In contrast to telomerase-positive cells, downregulation of hTERT had no effect on the expression of survivin in ALT-immortalized cells lines, including MRC5 cells immortalized by the combined action of SV40 ER and ALT. These results confirm the specificity the hTERT-siRNA and underscore the crucial role of hTERT in maintaining high levels of survivin in telomerase-positive cells. It was previously shown that hTERT-immortalized fibroblasts are resistant to stress-induced death, although the mechanism underlying this effect was not elucidated (Gorbunova et al., 2002) . The present investigation provides compelling evidence that resistance to cell death in telomerase-immortalized cells is a consequence of the upregulation of survivin. siRNAmediated knockdown of survivin in immortalized MRC5hTERT cells was shown to significantly increase the rate of spontaneous apoptosis and sensitize cells to drug-induced apoptosis. Conversely, overexpression of survivin in parental MRC5 and precrisis MRC5hTERT cells conferred resistance to drug-induced cell death. In contrast to immortal cells, spontaneous and druginduced apoptosis was not significantly altered by the downregulation of survivin in parental MRC5 or precrisis MRC5hTERT cells. Thus it appears that the abundant expression of endogenous survivin in immortal cells promoted their survival, whereas the low level of survivin expressed in precrisis MRC5hTERT and normal parental MRC5 cells was not protective. These results are consistent with studies that have shown survivin was dispensable for survival of normal human cells, as well as numerous reports that have demonstrated cytoprotection associated with high levels of survivin in tumor cells (Li et al., 1998; Mesri et al., 2001; Yang et al., 2004; Rodel et al., 2005) . The sensitivity of the immortal, but not mortal cells, to the ablation of survivin is also consistent with the oncogene addiction hypothesis posed to explain the dependence of cancer cells on continued expression of specific oncogenes (Weinstein and Joe, 2008) .
In summary, our investigations show that the expression of survivin is upregulated during hTERT-mediated immortalization of nontransformed human cells, and renders telomerase-immortalized cells resistant to apoptosis. These results support the notion that the upregulation of survivin in cancer cells is reflective of an oncogenic event and not simply a reflection of a higher mitotic index. Furthermore, we have shown that inhibition of hTERT very effectively suppresses both telomerase activity and expression of survivin. These results have broad therapeutic implications, as the activities of telomerase and survivin together underpin cellular survival, immortality and drug resistance; three properties that commonly manifest in diverse tumor types.
Materials and methods
Cell culture
Primary and immortal fetal lung fibroblasts, MRC5 and WI-38 were grown in a-Minimal Essential Medium (Invitrogen, Carlsbad, CA, USA) plus 10% fetal bovine serum (FBS; Thermo Scientific, Waltham, MA, USA) as previously described (Huschtscha and Holliday, 1983; MacKenzie et al., 2000; Milyavsky et al., 2003) . All other cell lines were maintained in Dulbecco's Modified Eagle's Medium (Invitrogen) plus 10% FBS. PD were calculated as PD ¼ logN/log2, where N is expansion. JFCF6 jejunal fibroblasts were immortalized following transfection with pCI-hTERT (Colgin et al., 2000) or SV40 ER. SV40 ER-transfected JFCF6 clones that spontaneously escaped crisis were isolated and determined to have either activated telomerase (JFCF6 T.1J/6B, T.1F, and T.1H) or maintained telomeres via ALT (JFCF-6T.1J/1-4D, T.1L, and T.1M; P Bonnefin and R Reddel, unpublished).
Apoptosis assays
The proportion of apoptotic cells was assessed by costaining with allophycocyanin (APC)-labeled Annexin V (BD Biosciences, San Jose, CA, USA) and PI (BD Biosciences) according to the manufacturer's instructions. Annexin V-positive and PI-negative cells were quantified using a FACS Calibur flow cytometer (BD Biosciences). Following 24-h treatment with 100 nM OA (Sigma, St Louis, MO, USA) or 1 mg/ml Act D (Sigma), the enzymatic activities of caspase-3/7 and caspase-9 were measured using a BD Apolert Caspase Assay Plate and incorporating inhibitors of caspase-3/7 and caspase-9 (DEVD-fmk and LEHD-fmk, respectively) as controls (BD Biosciences).
Immunoblot and immunofluorescence detection of survivin
Immunoblotting was performed as previously described (Taylor et al., 2004 ) using a rabbit anti-survivin antibody (NB500-201), purchased from Novus Biologicals (Littleton, CO, USA; Carvalho et al., 2003) , and an anti-caspase-7 rabbit polyclonal antibody from BD Biosciences. The membranes were stripped with Restore Western Blot Stripping Buffer (Pierce, Rockford, IL, USA) and reprobed using a rabbit antihuman actin antibody (Sigma). For immunofluorescence staining, cells were grown on a chamber slide (BD Biosciences), then fixed with freshly prepared 4% cold paraformaldehyde (ICN, Bryan, OH, USA) for 20 min, washed with phosphate-buffered saline (PBS) and permeabilized with cold 0.02% Triton X-100 (Sigma) for 30 s. The cells were then incubated with anti-survivin antibody in 0.5% bovine serum albumin/PBS and incubated with Alexa Fluor 594 goat antirabbit immunoglobulin-G (Invitrogen) at room temperature for 1 h. After washing with PBS, the cells were incubated in 0.3 mM 4 0 ,6-diamidino-2-phenylindole (DAPI; Invitrogen) for nuclear staining. The stained cells were viewed under a Zeiss Axioplan2 fluorescence microscope using an EpiPlan NeoFluor HD DIC Â 20 Objective (Carl Zeiss, Germany). Images were captured with a SensiCam CCD camera (Pco Computer Optics, Germany) using Image-ProPlus v4.1 software (Media Cybernetics Inc. Bethesda, MD, USA). Two investigators, blinded to the treatment, quantified survivin expression within the cytoplasm and nucleus. Five to six fields of view, each including 17-54 cells, were counted by each investigator.
Cell cycle analysis Cells were fixed in 70% ethanol, washed with PBS and stained with 100 mg/ml PI in a solution containing 50 mg/ml DNasefree RNase (Roche, Indianapolis, IN, USA). The percentage of cells in G 1 , S and G 2 /M phases were determined by FACS analysis using Cell Quest (BD Biosciences) and Modfit software (Verity Software House, Topsham, ME, USA).
qRT-PCR and Q-TRAP RNA was isolated using Trizol reagent and reverse transcribed using Superscript III reverse transcriptase and random primers (Invitrogen). Quantitative PCR reactions were performed on an ABI PRISM 7500 real-time PCR machine using ABI universal SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA). The sequence of primers for survivin were forward 5 0 -tctgcttcaaggagctggaagg-3 0 , reverse 5 0 -ttgttcttggctctttctctgtcc-3 0 ; primers for hTERT were forward 5 0 -tgacacctcacctcacccac-3 0 , reverse 5 0 -cactgtcttccgcaagttcac-3 0 ; primers for hTR were forward 5 0 -cgctgtttttctcgctgactt-3 0 , reverse 5 0 -tgctctagaatgaacggtggaa-3 0 ; primers for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were forward 5 0 -acccactcctccacctttga-3 0 , reverse 5 0 -ctgttgctgtagccaaattcgt-3 0 . All samples were amplified in duplicate and results were normalized to expression of GAPDH. Telomerase enzyme activity was quantified using the real-time PCR based Quantitative Telomerase Detection kit (Allied Biotech, Ijamsville, MD, USA) with previously described modifications (Schuller et al., 2007) .
Retroviral transductions
Transductions with retroviral MIGR1-survivin or MIGR1 were performed using Phoenix A packaging cells as previously described (Taylor et al., 2004; Gurbuxani et al., 2005) . Transduced cells were FACS-sorted based on GFP expression using a FACS Vantage cell sorter (BD Biosciences).
siRNA transfections
Oligonucleotide siRNAs with previously published sequence were chemically synthesized (Sigma) with a two-nucleotide overhang at the 3 0 end (Supplementary Table 1 ). Five additional hTERT siRNAs were designed using the BLOCK-iT RNAi designer program (Invitrogen) and the BIOPREDsi algorithm (Novartis Institutes for Biomedical Research, Basel, Switzerland) provided online by the Friedrich Miescher Institute for Biomedical Research, Basel. A scrambled siRNA (Sc) was used as a control. Cells were transfected with 100 nM siRNAs using Lipofectamine RNAiMAX reagent (Invitrogen) according to the manufacturer's recommended protocol.
